Jan‐Uwe Schreiber

ORCID: 0000-0002-0684-4840
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Anesthesia and Sedative Agents
  • Airway Management and Intubation Techniques
  • Cardiac, Anesthesia and Surgical Outcomes
  • Anesthesia and Pain Management
  • Intensive Care Unit Cognitive Disorders
  • Tracheal and airway disorders
  • Anesthesia and Neurotoxicity Research
  • Nausea and vomiting management
  • Inflammatory mediators and NSAID effects
  • Respiratory Support and Mechanisms
  • Pain Mechanisms and Treatments
  • Neuropeptides and Animal Physiology
  • Intraoperative Neuromonitoring and Anesthetic Effects
  • Congenital Heart Disease Studies
  • Cardiac and Coronary Surgery Techniques
  • Neonatal Respiratory Health Research
  • Venous Thromboembolism Diagnosis and Management
  • EEG and Brain-Computer Interfaces
  • Cardiac Arrest and Resuscitation
  • Potassium and Related Disorders
  • Cardiac Valve Diseases and Treatments
  • Atrial Fibrillation Management and Outcomes
  • COVID-19 and healthcare impacts
  • Biomedical and Chemical Research
  • Pediatric Pain Management Techniques

Maastricht University
2009-2024

Maastricht University Medical Centre
2011-2024

Universitätsklinikum Würzburg
2017

University Medical Center
2009-2014

Saarland University
2001-2011

May Institute
2010

Centre Hospitalier Régional et Universitaire de Nancy
2009

Universitätsklinikum des Saarlandes
2002-2006

University of Rostock
2005

Université de Lorraine
2003

Background Vocal cord injuries, postoperative hoarseness, and sore throat are common complications after general anesthesia. One-lung ventilation can be achieved via two techniques: double-lumen endotracheal tube or endobronchial blocker such as the Arndt blocker. The current study was designed to assess impact of these techniques for one-lung on incidence severity vocal lesions, throat. Methods In this prospective trial, 60 patients were randomly assigned groups. with either an (blocker...

10.1097/00000542-200609000-00009 article EN Anesthesiology 2006-08-24

ANDEXANET ALFA (Ondexxya, Portola Pharmaceuticals, San Francisco, CA) is a modified recombinant inactivated human factor Xa. Although it currently only approved to reverse the effects of direct Xa (FXa) inhibitors, andexanet alfa initially was developed as reversal agent for and indirect FXa inhibitors.1 The acts decoy molecule that reversibly binds inhibitors consequently temporarily inhibits anticoagulant effects. In vitro studies showed binding affinity heparin-bound antithrombin...

10.1053/j.jvca.2020.10.042 article EN cc-by Journal of Cardiothoracic and Vascular Anesthesia 2020-10-24

In Brief Postoperative hoarseness (PH), sore throat (ST), and vocal cord injuries (VCI) are common complications after general anesthesia. Excellent endotracheal intubating conditions associated with less laryngeal morbidity than good or poor conditions. Thus, we tested the hypothesis that a rapid-sequence induction (RSI) succinylcholine would lead to PH VCI rocuronium. this prospective trial, 160 patients were randomized in 2 groups receive thiopental 5.0 mg/kg, fentanyl 3.0 μg/kg, 1.0...

10.1213/01.ane.0000194509.03916.02 article EN Anesthesia & Analgesia 2006-02-14

Background: Acceleromyography has been shown to be an appropriate method in the detection of residual paralysis. However, clinical importance individual calibration device single patient improve reliability detecting paralysis remains unclear. Methods: Observational study 100 patients undergoing general anaesthesia with endotracheal intubation and a neuromuscular block atracurium. In all patients, individually calibrated acceleromyograph was used estimate possible at end surgery. Immediately...

10.1111/j.1399-6576.2010.02378.x article EN Acta Anaesthesiologica Scandinavica 2011-02-02

This study was designed to investigate the impact of patient age on propofol consumption and recovery time using a propofol-remifentanil anaesthetic standardized with Narcotrend EEG monitoring. The is monitor for measuring depth anaesthesia based upon six-letter classification from A (awake) F (increasing burst suppression) including 14 substages.In 200 patients scheduled minor orthopaedic surgery electrodes were positioned patient's forehead as recommended by manufacturer. Anaesthesia...

10.1017/s0265021505000232 article EN European Journal of Anaesthesiology 2005-02-01

Background: The purpose of this study was to investigate whether gender influences the perception pain on injection rocuronium. Methods: In prospective, placebo‐controlled trial 120 patients were randomized into four groups receive rocuronium 0.03 mg kg −1 (40 female and 40 male patients) or saline (20 20 patients). incidence severity after administration drug compared between using a numerical rating scale (0–10). Signs local irritation, i.e. erythema thrombophlebitis, assessed up 48 h...

10.1111/j.1399-6576.2004.00506.x article EN Acta Anaesthesiologica Scandinavica 2004-10-25

Succinylcholine is a popular muscle relaxant for ambulatory anesthesia (1). Unfortunately, postoperative myalgia (POM) may frequently occur after the use of succinylcholine (2–7) and this be particularly troublesome in outpatients (3,5,6). Although pretreatment with nondepolarizing myorelaxants seems to effective decreasing fasciculation, its effectiveness reducing POM controversial (5,6). Moreover, produce weakness preceding loss consciousness (8). Interestingly, increasing evidence...

10.1097/00000539-200203000-00018 article EN Anesthesia & Analgesia 2002-03-01

A common side effect associated with succinylcholine is postoperative myalgia. The pathogenesis of this myalgia still unclear; inflammation has been suggested but without convincing evidence. We designed the present study to investigate whether an inflammatory reaction contributes incidence and severity succinylcholine-associated was determined in 64 patients pretreated saline or dexamethasone before (n = 32 for each). Incidence did not differ significantly between two groups: 15 group...

10.1213/01.ane.0000061220.70623.70 article EN Anesthesia & Analgesia 2003-06-01
Coming Soon ...